GB0604778D0 - Use of substituted amine compouds fo the treatment of food related disorders - Google Patents

Use of substituted amine compouds fo the treatment of food related disorders

Info

Publication number
GB0604778D0
GB0604778D0 GBGB0604778.1A GB0604778A GB0604778D0 GB 0604778 D0 GB0604778 D0 GB 0604778D0 GB 0604778 A GB0604778 A GB 0604778A GB 0604778 D0 GB0604778 D0 GB 0604778D0
Authority
GB
United Kingdom
Prior art keywords
compouds
treatment
related disorders
substituted amine
food related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0604778.1A
Other versions
GB2435826A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to GB0604778A priority Critical patent/GB2435826A/en
Publication of GB0604778D0 publication Critical patent/GB0604778D0/en
Publication of GB2435826A publication Critical patent/GB2435826A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0604778A 2006-03-09 2006-03-09 Use of substituted amine compounds in the treatment of food related disorders Withdrawn GB2435826A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0604778A GB2435826A (en) 2006-03-09 2006-03-09 Use of substituted amine compounds in the treatment of food related disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0604778A GB2435826A (en) 2006-03-09 2006-03-09 Use of substituted amine compounds in the treatment of food related disorders

Publications (2)

Publication Number Publication Date
GB0604778D0 true GB0604778D0 (en) 2006-04-19
GB2435826A GB2435826A (en) 2007-09-12

Family

ID=36241302

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0604778A Withdrawn GB2435826A (en) 2006-03-09 2006-03-09 Use of substituted amine compounds in the treatment of food related disorders

Country Status (1)

Country Link
GB (1) GB2435826A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2725977T3 (en) * 2014-12-15 2019-10-01 Esteve Pharmaceuticals Sa Methyl-1H-pyrazolalkylamine compounds that have multimodal activity against pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681322B1 (en) * 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa DERIVATIVES OF ARYL-HETEROARYL- {N- [2- (3,4-DIMETHOXYPHENYL) -ETHYL] -N-METHYL-3-AMINOPROPOXY} -METHANE THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
WO1999015129A2 (en) * 1997-09-23 1999-04-01 Bristol-Myers Squibb Company SELECTIVE cPLA2 INHIBITORS

Also Published As

Publication number Publication date
GB2435826A (en) 2007-09-12

Similar Documents

Publication Publication Date Title
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
HK1202441A1 (en) Methods of treating gastrointestinal disorders independent of the intake of food
IL201309A0 (en) Novel n - (8 - heteroaryltetrahydronaphtalene - 2yl) or n - (5 - heteroarylchromane - 3 - yl) carboxamide derivatives for the treatment of pain
EP1976377A4 (en) Compounds for the treatment of metabolic disorders
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
EP1983972A4 (en) Compounds for the treatment of metabolic disorders
IL195203A0 (en) Compounds for the treatment of metabolic disorders
EP2139475A4 (en) The use of pde7 inhibitors for the treatment of movement disorders
HK1247943A1 (en) Treatment of development-related disorders
IL192852A0 (en) Compounds for the treatment of metabolic disorders
IL205578A0 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders
ZA200806455B (en) Use of 2-imidazoles for the treatment of CNS disorders
EP2077838A4 (en) Methods for the treatment of a related disorders and compositions therefor
IL197695A0 (en) 3-amino-pyridine derivatives for the treatment of metabolic disorders
IL192877A0 (en) Use of 2-imidazoles for the treatment of cns disorders
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB0604780D0 (en) Use of substituted piperazine compounds for the treatment of food related disorders
IL192851A0 (en) Compounds for the treatment of metabolic disorders
GB0604781D0 (en) Use of substituted phenyl-piperazine compounds for the treatment of food related disorders
EP2026659A4 (en) Compounds for the treatment of metabolic disorders
GB0604782D0 (en) Use of substituted pyrimidinyl-2-piperazine compounds for the treatment of food related disorders
GB0604778D0 (en) Use of substituted amine compouds fo the treatment of food related disorders
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders
GB0604783D0 (en) Use of substituted oxime compounds for the treatment of food related disorders
GB0602857D0 (en) The treatment of sialorrhoea

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)